drugset / Trial / NCT07313371

Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder

NCT07313371

Phase 4 Recruiting 36 enrolled University of Sao Paulo General Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single-center, randomized intervention study in a volunteer population of patients with cocaine/crack use disorder to evaluate the pharmacological treatment of cocaine/crack craving, comparing the drug clonidine with the active placebo clonazepam.

Timeline

Start
2026-01-28
Primary completion
2026-07
Completion
2027-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clonazepam Small molecule 0.25 mg
Subject Clonidine Other / unclassified 0.1 mg

Indications